Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Non Operating Investment Income: 2019-2024

Historic Non Operating Investment Income for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to -$1,000.

  • Benitec Biopharma's Non Operating Investment Income rose 66.67% to -$1,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$7,000, marking a year-over-year decrease of 16.67%. This contributed to the annual value of -$1,000 for FY2024, which is 66.67% up from last year.
  • Latest data reveals that Benitec Biopharma reported Non Operating Investment Income of -$1,000 as of FY2024, which was up 66.67% from -$3,000 recorded in FY2023.
  • Benitec Biopharma's 5-year Non Operating Investment Income high stood at $16,000 for FY2021, and its period low was -$11,000 during FY2022.
  • In the last 3 years, Benitec Biopharma's Non Operating Investment Income had a median value of -$3,000 in 2023 and averaged -$5,000.
  • In the last 5 years, Benitec Biopharma's Non Operating Investment Income surged by 1,700.00% in 2021 and then plummeted by 168.75% in 2022.
  • Over the past 5 years, Benitec Biopharma's Non Operating Investment Income (Yearly) stood at -$1,000 in 2020, then surged by 1,700.00% to $16,000 in 2021, then tumbled by 168.75% to -$11,000 in 2022, then soared by 72.73% to -$3,000 in 2023, then spiked by 66.67% to -$1,000 in 2024.